title: Surveillance of HIV in the United States and England, Scotland, and Northern Ireland: what have we learned and what do we do about it?
authors.affiliation: From the Department of Medicine, Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.
authors.forename: Cynthia
authors.initials: C
authors.lastname: Gay
authors.forename: Ada
authors.initials: A
authors.lastname: Adimora
authors.forename: William
authors.initials: W
authors.lastname: Miller
authors.forename: Myron S
authors.initials: MS
authors.lastname: Cohen
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000453:epidemiology*; D057210:Delayed Diagnosis / Q000639:trends*; D005260:Female; D015658:HIV Infections / Q000453:epidemiology*; D006679:HIV Seropositivity / Q000175:diagnosis*; D006297:Health Services Accessibility / Q000639:trends*; D006525:Hepatitis, Viral, Human / Q000453:epidemiology*; D006558:Herpes Genitalis / Q000453:epidemiology*; D020010:Heterosexuality; D018451:Homosexuality, Male; D006801:Humans; D008297:Male; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data*; D011787:Quality of Health Care / Q000639:trends*; D015819:Substance Abuse, Intravenous / Q000453:epidemiology*
chemical_list: D019380:Anti-HIV Agents